Back to Journals » Vascular Health and Risk Management » Volume 16

Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan

Total article views   Abstract views HTML views PDF downloads Totals
6,098 Dovepress* 3,147 1,321+ 1,460 4,468
PubMed Central* 0 1,630 435 1,630
Totals 3,147 2,951 1,895 6,098
*Since 16 January 2020
+Since July 2016

View citations on PubMed Central and Google Scholar